The Aequs IPO is a closed mainboard Bookbuilding offer (Fresh Capital-cum-Offer for Sale) that opened on 3 December 2025. The Aequs IPO closed on 5 December 2025, with an issue price of ₹124 per share. The Aequs IPO has a face value of ₹10 and a lot size of 120 shares. The Aequs IPO is listed on 10 December 2025. The Aequs IPO allotment was scheduled for 8 December 2025.
On the financial front, the Aequs IPO reported revenue of ₹566 crore for 30 Sep 2025, compared with ₹959 crore for 31 Mar 2025. The Aequs IPO PAT was ₹-17 crore against ₹-102 crore. The Aequs IPO EBITDA stood at ₹84 crore with a 11.68% margin. The Aequs IPO net worth as of 30 Sep 2025 was ₹796 crore.
Always verify The Aequs IPO details and GMP data with the official offer document before investing in the Aequs IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Sep 2025
31 Mar 2025
30 Sep 2024
Total Assets
2,134
1,860
1,864
Revenue
566
959
476
PAT
-17
-102
-72
EBITDA
84
108
58
Net Worth
796
708
732
Reserves
200
135
-91
Total Borrowing
534
437
385
Aequs IPO Financials FAQs
Revenue of Aequs (Amount in ₹ Crore) — 30 Sep 2025: 566; 31 Mar 2025: 959; 30 Sep 2024: 476. Profit after tax (PAT) — 30 Sep 2025: -17; 31 Mar 2025: -102; 30 Sep 2024: -72.
EBITDA of Aequs (Amount in ₹ Crore) — 30 Sep 2025: 84; 31 Mar 2025: 108; 30 Sep 2024: 58. The EBITDA margin is 11.68%.
Total assets — 30 Sep 2025: 2,134; 31 Mar 2025: 1,860; 30 Sep 2024: 1,864. Net worth — 30 Sep 2025: 796; 31 Mar 2025: 708; 30 Sep 2024: 732. Reserves & surplus — 30 Sep 2025: 200; 31 Mar 2025: 135; 30 Sep 2024: -91. (Amount in ₹ Crore)
Total borrowing of Aequs (Amount in ₹ Crore) — 30 Sep 2025: 534; 31 Mar 2025: 437; 30 Sep 2024: 385. Debt-to-equity ratio: 0.99.
The financials shown for Aequs IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
